ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,827.46
      -0.13%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Pyxis Oncology Inc (PYXS) Quote

      Pyxis Oncology Inc

      Pyxis Oncology Inc (PYXS)

      NASDAQ
      3.88
      0.03
      (0.78%)
      Closed July 27 4:00PM
      Delayed by 15 minutes
      3.84
      -0.04
      (-1.03%)
      After Hours: 6:27PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      3.84
      Bid
      3.84
      Ask
      4.19
      Volume
      320,243
      3.81 Day's Range 4.05
      1.35 52 Week Range 6.85
      Market Cap
      226.132M
      Previous Close
      3.85
      Open
      3.95
      Last Trade
      20
      @
      3.96
      Last Trade Time
      Financial Volume
      $ 1,249,061
      VWAP
      3.9004
      Average Volume (3m)
      492,971
      Shares Outstanding
      58,888,473
      Dividend Yield
      -
      PE Ratio
      -3.09
      Earnings Per Share (EPS)
      -1.25
      Revenue
      -
      Net Profit
      -73.79M

      About Pyxis Oncology Inc

      Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the ... Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      pyxisoncology.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Pyxis Oncology Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PYXS. The last closing price for Pyxis Oncology was $3.85. Over the last year, Pyxis Oncology shares have traded in a share price range of $ 1.35 to $ 6.85.

      Pyxis Oncology currently has 58,888,473 shares outstanding. The market capitalization of Pyxis Oncology is $226.72 million. Pyxis Oncology has a price to earnings ratio (PE ratio) of -3.09.

      PYXS Latest News

      More News

      Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers...

      June 28 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      June 12 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 10 2024
      Edgar (US Regulatory)

      Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger

      BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers...

      June 10 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      June 07 2024
      Edgar (US Regulatory)

      Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference

      BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers...

      May 30 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      May 14 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      May 14 2024
      Edgar (US Regulatory)

      Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024

      PYX-201 Phase 1 trial clinical readout on track for fall of 2024 Executive Leadership Team expanded with the appointment of Stephen Worsley as Senior Vice President, Chief Business Officer...

      May 14 2024
      GlobeNewswire Inc.

      Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference

      BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers...

      May 09 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.5918.15384615383.254.133.235335483.73473853CS
      40.5617.07317073173.284.132.816374053.24717876CS
      12-0.66-14.66666666674.54.782.814929713.58123293CS
      260.6921.90476190483.156.852.816944014.48376777CS
      521.3956.73469387762.456.851.354336393.99720773CS
      156-15.16-79.789473684219191.15938764.20621414CS
      260-15.16-79.789473684219191.15938764.20621414CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WINTWindtree Therapeutics Inc
      $ 8.24
      (150.46%)
      		48.57M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NBSTWNewbury Street Acquisition Corporation
      $ 0.1349
      (92.71%)
      		122.1k
      YIBOPlanet Image International Ltd
      $ 2.915
      (53.43%)
      		260.07k
      CREVCarbon Revolution Public Ltd
      $ 9.00
      (45.87%)
      		8.06M
      NMHINatures Miracle Holding Inc
      $ 0.2035
      (-48.06%)
      		7.69M
      TANHTantech Holdings Ltd
      $ 0.2585
      (-47.23%)
      		6.75M
      DXCMDexCom Inc
      $ 64.00
      (-40.66%)
      		53.92M
      PSIGPS International Group Ltd
      $ 1.42
      (-31.40%)
      		716.26k
      POAIPredictive Oncology Inc
      $ 1.36
      (-27.27%)
      		6.02M
      SLNASelina Hospitality PLC
      $ 0.0305
      (-18.88%)
      		408.61M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NVDANVIDIA Corporation
      $ 113.06
      (0.69%)
      		293.33M
      SQQQProShares UltraPro Short QQQ
      $ 9.10
      (-2.88%)
      		176.49M
      SGMOSangamo Therapeutics Inc
      $ 0.8612
      (28.15%)
      		123.71M

      PYXS Discussion

      View Posts
      Monksdream Monksdream 4 months ago
      PYXS under $5
      👍️0
      Awl416 Awl416 5 months ago
      Pyxis Oncology Announces $50 Million Private Placement
      👍️0
      euroconversions euroconversions 11 months ago
      Insiders buying, always a good sign.
      PYXS Long
      👍️0
      jack7377 jack7377 1 year ago
      PYSX#$$: Hey Bulba and JuneBugs , this Log Legged Loin Puppy is getting ready to Break it's Chain,Leap and go on an Epic Run North. Friday's 1st Qtr Financials are going to make this spring 200-300%.
      👍️0
      TheFinalCD TheFinalCD 1 year ago
      I did, nice P&D

      https://www.tiktok.com/@stockdads/video/7217125391520091434
      👍️0
      SpaceTimeRift777 SpaceTimeRift777 1 year ago
      Wouldn't touch it until we see if that $3 support can hold
      GL
      👍️0
      spencer22 spencer22 1 year ago
      Perfect example of dilution,in other words a classic pump and dump in my opinion!
      👍️ 1
      0210 0210 1 year ago
      7). $10.75 PYXS Target Price @ Fin Viz.

      8). BUY Rating $14.00 PYXS PT @ Market Beat.

      9). $10.75 PT +++Positive+++ Short, Medium and Long Term Performance Outlook, Yahoo Finance.

      10). BUY Rating @Reuters.
      👍️0
      0210 0210 1 year ago
      buyin' dips $4.00 - $4.10. 14m BUYs (+5m?) vs. 12m Sells this Friday. hmmm.....

      1). 88% Buy, up from 72% buy last week and 40% Buy, a month ago @Barchart.

      2). Stay Long @ American Bulls.

      3). $10.75 Price Target, from 5 analysts @Barrons.

      4). $4.00 >$11.50 > $16.00 Price Targets @CNN Business.

      5). HOLD Rating @ Zacks.

      6). $11.22 TP mean rating, Chartmill.
      👍️0
      interloper interloper 1 year ago
      I just heard the same thing from a cousin who said it was on Reddit.
      👍️0
      Jess070283 Jess070283 1 year ago
      That dip was a gift. Loaded way oversold.
      👍️0
      magacrew2020 magacrew2020 1 year ago
      potential halt at $2. seems to be fair value
      👍️0
      da_stock_analyst da_stock_analyst 1 year ago
      #PYXS ?? big squeeze coming??!! Attractive bullish chart! $PYXS
      👍️0
      Pyramid2 Pyramid2 1 year ago
      * * > $7 halt < * *

      Went short $6.85 and they halted it $6.92 and she dropped. I thought not again just like SVIBQ and it will open 2 weeks later at $100. I am still waiting to get my trading groove back. This thing has been a rocket from $3.92 yesterday. No position now closed out on $6 close.

      glta.
      👍️0
      SpaceTimeRift777 SpaceTimeRift777 1 year ago
      Better lock profits today this will come back down to earth

      Way Overbought
      👍️0
      SpaceTimeRift777 SpaceTimeRift777 1 year ago
      One hell of a Moon Market pump
      👍️0
      jakec21 jakec21 1 year ago
      Please post something that you have proof. You r on my radar alert
      👍️0
      TrendTrade2016 TrendTrade2016 1 year ago
      PYXS....MONSTER TAKING OFF!!
      👍️0
      PickItToWin PickItToWin 1 year ago
      Thorough DD is how I found my info and jumped in at $2. Definitely happy with my ROI this week, hope others took advantaged as well. GLTA
      👍️0
      eastunder eastunder 1 year ago
      It's from a tiktok video...

      Where all valid information comes from.
      👍️0
      da_stock_analyst da_stock_analyst 1 year ago
      #PYXS ?? can it double from here? very bullish chart! see the video $PYXS
      👍️0
      TheFinalCD TheFinalCD 1 year ago
      hmmmm, any info or articles to back your post up?


      Message in reply to:
      Target price is $12-$16. Nancy Pelosi’s husband just scooped up a bunch of PYXS and he somehow always has the inside scoop on stocks ;)
      👍️0
      Jess070283 Jess070283 1 year ago
      Beast!$$$
      👍️0
      Randyfloyd420 Randyfloyd420 1 year ago
      Yea what a joke
      👍️0
      eastunder eastunder 1 year ago
      I did. There is nothing that I found that backed that up.

      So if you have something, cam you please post a link?

      I really am curious.

      I don't see Pelosi buying something like this.

      Why?
      👍️0
      PickItToWin PickItToWin 1 year ago
      Just do a Google search on Pyxs and Nancy Pelosi. She’s not the only one buying it up.
      👍️0
      eastunder eastunder 1 year ago
      How do you know that?
      👍️0
      PickItToWin PickItToWin 1 year ago
      Target price is $12-$16. Nancy Pelosi’s husband just scooped up a bunch of PYXS and he somehow always has the inside scoop on stocks ;)
      👍️0
      Amatuer17 Amatuer17 1 year ago
      Seems an interesting play in ADC
      👍️0

      Your Recent History

      NASDAQ
      PYXS
      Pyxis Oncology
      USOTC
      PSRU
      Valiant Eagle (PK)
      BIT
      UCG
      Unicredit
      BIT
      P11PR2
      BNP Paribas Arbitrage Is...
      COIN
      AWCUSD
      Atomic Wallet Token
      Delayed Upgrade Clock